Back

A comparison of prolonged anticoagulation versus no anticoagulation after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

31 August 2024 (17:03 - 17:15)
Organised by: Logo
Congress Presentation Part of: Trial updates and other studies on percutaneous coronary intervention Anticoagulants ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Yan Yan

Beijing Anzhen Hospital, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Clopidogrel following 1-month aspirin-free low-dose prasugrel monotherapy versus aspirin following 1-month DAPT after PCI for patients with ACS or HBR: Final 1-year results from the STOPDAPT-3
Doctor H. Watanabe (Hirakata, JP)
Slides Video
Presentation thumbnail
Long-Term Outcomes with PCI Guided by Fractional Flow Reserve
Doctor C. Collet (New York, US)
Slides Video
Presentation thumbnail
Titanium-nitride-oxide-coated vs drug-eluting stents in acute coronary syndromes during five-year follow-up: an individual patient data meta-analysis
Doctor T. Mahendiran (Aalst, BE)
Slides Video
Presentation thumbnail
Physiology-guided complete versus culprit-only PCI in older MI patients
Associate Professor S. Biscaglia (Ferrara, IT)
Slides Video

Access the full session

Session thumbnail
Trial updates and other studies on percutaneous coronary intervention
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 17:03 CET
You may be interested in
thumbnail
Congress Presentation
RIGHT: Prolongation of anticoagulation after Primary PCI
thumbnail
Congress Session
HOT LINE 9
thumbnail
Congress Session
Trial updates and other studies on percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources